Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study

Cancer Research

Volumn 58, Issue 4, 1998, Pages 667-671

  Ishibe, Naoko ^a   Hankinson, Susan E ^a,c   Colditz, Graham A ^a,b,c   Spiegelman, Donna ^a   Willett, Walter C ^a,c   Speizer, Frank E ^a,c   Kelsey, Karl T ^a,b,c   Hunter, David J ^a,b,c,d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD CENTER FOR CANCER PREVENTION   (United States)

^c HARVARD UNIVERSITY   (United States)

^d CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; POLYCYCLIC AROMATIC HYDROCARBON;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BIOTRANSFORMATION; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CIGARETTE SMOKING; DNA ADDUCT; DNA POLYMORPHISM; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGE FACTORS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; FEMALE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RISK; SMOKING;

EID: 0032519805     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Davis, D. L., Bradlow, H. L., Wolff, M., Woodruff, T., Hoel, D. G., and Anton-Culver, H. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ. Health Perspect., 101: 372-377, 1993.
2. Cavalieri, N., Rogan, E., and Sinha, D. Carcinogenicity of aromatic hydrocarbons directly applied to rat mammary gland. J. Cancer Res. Clin. Oncol., 114: 3-9, 1988.
3. Chatterjee, M., and Banerjee, M. R. Selenium mediated dose-inhibition of 7,12-dimethylbenz[a]anthracene-induced transformation of mammary cells in organ culture. Cancer Lett., 17: 187-195, 1982.
4. Fun, B. J., and Jordan, V. C. The pharmacology and clinical uses of tamoxifen. Pharmacol. Ther., 25: 127-205, 1984.
5. Russo, J., and Russo, I. H. Biological and molecular basis of mammary carcinogenesis. Lab. Invest., 57: 112-137, 1987.
6. Calaf, G., and Russo, J. Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis (Lond.), 14: 483-492, 1993.
7. John, E. M., and Kelsey, J. L. Radiation and other environmental exposures and breast cancer. Epidemiol. Rev., 15: 7-16, 1993.
8. Palmer, J., and Rosenberg, L. Cigarette smoking and the risk of breast cancer. Epidemiol. Rev., 15: 145-156, 1993.
9. Baron, J. A., Newcomb, P. A., Longnecker, M. P., Mittendorf, R., Storer, B. E., Clapp, R. W., Bogdan, G., and Yuen, J. Cigarette smoking and breast cancer. Cancer Epidemiol. Biomarkers Prev., 5: 399-403, 1996.
10. London, S. J., Colditz, G. A., Stampfer, M. J., Willett, W. C., Rosner, B. A., and Speizer, F. E. Prospective study of smoking and the risk of breast cancer. J. Natl. Cancer Inst., 81: 1625-1631, 1989.
11. MacMahon, B. Cigarette smoking and cancer of the breast. In: N. Wald and J. Baron (eds.), Smoking and Hormone Related Disorders, pp. 154-66. Oxford, United Kingdom: Oxford University Press, 1990.
12. Petrakis, N. L., Maack, C. A., Lee, R. E., and Lyon, M. Mutagenic activity in nipple aspirates of human breast fluid. Cancer Res., 40: 188-189, 1980.
13. Petrakis, N. L., Gruenke, L. D., Beelen, T. C., Castagnoli, N., Jr., and Craig, J. C. Nicotine in breast fluid of nonlactating women. Science (Washington DC), 199: 303-304, 1978.
14. Perera, F. P., Estabrook, A., Hewer, A., Channing, K., Rundle, A., Mooney, L. A., Whyatt, R., and Phillips, D. H. Carcinogen-DNA adducts in human breast tissue. Cancer Epidemiol. Biomarkers Prev., 4: 233-238, 1995.
15. Li, D., Wang, M., Dhingra, K., and Hittelman, W. N. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res., 56: 287-293, 1996.
16. Pelkonen, O., and Nebert, D. W. Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacol. Rev., 34: 189-222, 1982.
17. Law, M. R. Genetic predisposition to lung cancer. Br. J. Cancer, 61: 195-206, 1990.
18. Crofts, F., Taioli, E., Trachman, J., Cosma, G. N., Currie, D., Toniolo, P., and Garte, S. J. Functional significance of different human CYP1A1 genotypes. Carcinogenesis (Lond.), 15: 2961-2963, 1994.
19. Cosma, G., Crofts, F., Taioli, E., Toniolo, P., and Garte, S. Relationship between genotype and function of the human CYPA1 gene. J. Toxicol. Environ. Health, 40: 309-316, 1993.
20. Jacquet, M., Lambert, V., Baudoux, E., Muller, M., Kremers, P., and Gielen, J. Correlation between P450 CYP1A1 inducibility, MspI genotype, and lung cancer incidence. Eur. J. Cancer, 32A: 1701-1706, 1996.
21. Wedlund, P. J., Kimura, S., Gonzalez, F. J., and Nebert, D. W. 1462V mutation in the human CYP1A1 gene: lack of correlation with either MspI 1.9 kb (m2) allele or CYP1A1 inducibility in a three-generation family of east Mediterranean descent. Pharmacogenetics, 4: 21-26, 1994.
22. Zhang, Z. Y., Fasco, M. J., Huang, L., Guengerich, F. P., and Kaminsky, L. S. Characterization of purified human recombinant cytochrome P4501A1-Ile462 and -Val462: assessment of role for the rare allele in carcinogenesis. Cancer Res., 56: 3926-3933, 1996.
23. Kawajiri, K., Nakachi, K., Imai, K., Watanabe, J., and Hayashi, S. I. The CYP1A1 gene and cancer susceptibility. Crit. Rev. Oncol. Hematol., 14: 77-87, 1993.
24. Landi, M. T., Bertazzi, P. A., Shields, P. G., Clark, G., Lucier, G. W., Garte, S. J., Cosma, G., and Caporaso, N. E. Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics, 4: 242-246, 1994.
25. Persson, I., Johansson, I., and Ingelman-Sundberg, M. In vitro kinetics of two human CYP1A1 variant enzymes suggested to be associated with interindividual differences in cancer susceptibility. Biochem. Biophys. Res. Commun., 231: 227-230, 1997.
26. Kawajiri, K., Eguchi, H., Nakachi, K., Sekiya, T., and Yamamoto, M. Association of CYP1A1 germ line polymorphisms with mutations of the p53 gene in lung cancer. Cancer Res., 56: 72-76, 1996.
27. Xu, X., Kelsey, K. T., Wiencke, J. K., Wain, J. C., and Christiani, D. C. Cytochrome P450 1A1 MspI polymorphism and lung cancer susceptibility. Cancer Epidemiol. Biomarkers Prev., 5: 687-692, 1996.
28. Sugimura, H., Hamada, G. S., Suzuki, I., Iwase, T., Kiyokawa, E., Kino, I., and Tsugane, S. CYP1A1 and CYP2E1 polymorphism and lung cancer, case-control study in Rio de Janeiro, Brazil. Pharmacogenetics, 5: S145-S148, 1995.
29. Greiner, J. W., Malan-Shibley, L. B., and Janss, D. H. Detection of aryl hydrocarbon hydroxylase activity in normal and neoplastic human breast epithelium. Life Sci., 26: 313-319, 1980.
30. Pyykko, K., Tuimala, R., Aalto, L., and Perkio, T. Is aryl hydrocarbon hydroxylase activity a new prognostic indicator for breast cancer? Br. J. Cancer, 63: 596-600, 1991.
31. McKay, J. A., Murray, G. I., Ah-see, A. K., Greenlee, W. F., Craig, B. M., Burke, M. D., and Melvin, W. T. Differential expression of CYP1A1 and CYP1B1 in human breast cancer. Biochem. Soc. Transact., 24: 327S, 1996.
32. Nebert, D. W. Role of genetics and drug metabolism in human cancer risk. Mutat. Res., 247: 267-281, 1991.
33. Rebbeck, T. R., Rosvole, E. A., Duggan, D. J., Zhang, J., and Buetow, K. H. Genetics of CYP1A1: coamplificauon of specific alleles by polymerase chain reaction and association with breast cancer. Cancer Epidemiol. Biomarkers Prev., 3: 511-514, 1994.
34. Ambrosone, C. B., Freudenheim, J. L., Graham, S., Marshall, J. R., Vena, J. E., Erasure, J. R., Laughlin, R., Nemoto, T., Michalek, A. M., Harrington, A., and Shields, P. G. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res., 55: 3483-3485, 1995.
35. Taioli, E., Trachman, J., Chen, X., Toniolo, P., and Garte, S. J. A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res., 55: 3757-3758, 1995.
36. Walsh, P. S., Metzger, D. A., and Higuchi, R. Chelex® 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. BioTechniques, 10: 506-513, 1991.
37. Kawajiri, K., Nakachi, K., Imai, K., Yoshii, A., Shinoda, N., and Watanabe, J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450 1A1 gene. FEBS Lett., 263: 131-133, 1990.
38. Cheng, T. J., Christiani, D. C., Xu, X., Wain, J. C., Wiencke, J. K., and Kelsey, K. T. Glutathione S-transferase M1 genotype, diet, and smoking as determinants of sister chromatid exchange frequency in lymphocytes. Cancer Epidemiol. Biomarkers Prev., 4: 535-542, 1995.
39. Miettinen, O. S. Proportion of disease caused or prevented by a given exposure, trait or intervention. Am. J. Epidemiol., 99: 325-332, 1974.
40. Palmer, J. R., Rosenberg, L., Clarke, E. A., Stoltey, P. D., Warshauer, M. E., Zauber, A. G., and Shapiro, S. Breast cancer and cigarette smoking: a hypothesis. Am. J. Epidemiol., 134: 1-13, 1991.
41. Rothman, K. J. Causal inference in epidemiology. In: Modern Epidemiology, pp. 11-13. Boston: Little, Brown, and Co., 1986.
42. 1 450) gene: lack of association between the MspI restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population. Pharmacogenetics, 1: 20-25, 1991.
43. Hom-Ross, P. L. Phytoestrogens, body composition, and breast cancer. Cancer Causes Control, 6: 567-573, 1995.